HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Alpha-fetoprotein producing gastric cancer responding to combined chemotherapy with UFT and adriamycin].

Abstract
A case of AFP producing gastric carcinoma with liver metastasis that showed marked response to combined chemotherapy with UFT and Adriamycin (ADM) is reported. A 61-year-old man was admitted because of lassitude and abdominal fullness. An upper GI series and computed tomography revealed gastric cancer (Borrmann III) and multiple liver tumors. He had a remarkably high serum AFP level (90,000 ng/ml) and a high CEA level (270 ng/ml). The presence of AFP in the tumor cells of the biopsy specimen was proved immunohistochemically. He was treated with 600 mg of UFT orally every day and ADM (10 mg, iv, on days 1-4, repeated every 14 days), resulting in marked regression (PR, partial response) of both the primary tumor and liver metastasis on the 33 rd day after the start of treatment, with decreasing of serum levels of AFP and CEA. The patient has been asymptomatic without evidence of recurrence for a follow-up period of more than three months with continuing treatment in our outpatient clinic. UFT-ADM therapy appears to be useful for gastric cancer.
AuthorsK Koda, N Ito, S Matsumoto, T Terui, M Oda, S Terada, T Kure, O Nakazawa
JournalGan no rinsho. Japan journal of cancer clinics (Gan No Rinsho) Vol. 32 Issue 11 Pg. 1482-5 (Sep 1986) ISSN: 0021-4949 [Print] Japan
PMID2430121 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • alpha-Fetoproteins
  • Tegafur
  • Uracil
  • Doxorubicin
Topics
  • Adenocarcinoma (drug therapy, metabolism)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Doxorubicin (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Stomach Neoplasms (drug therapy, metabolism)
  • Tegafur (administration & dosage)
  • Uracil (administration & dosage)
  • alpha-Fetoproteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: